Increased Expression and Activity of 12-Lipoxygenase in Oxygen-Induced Ischemic Retinopathy and Proliferative Diabetic Retinopathy
Implications in Retinal Neovascularization
- Mohamed Al-Shabrawey1,2,3,4,
- Rene Mussell1,
- Khalid Kahook1,
- Amany Tawfik1,
- Mohamed Eladl4,
- Vijay Sarthy5,
- Julian Nussbaum2,
- Ahmed El-Marakby1,
- Sun Young Park6,
- Zafer Gurel6,
- Nader Sheibani6 and
- Krishna Rao Maddipati7
- 1Department of Oral Biology and Anatomy, Medical College of Georgia, Augusta, Georgia
- 2Ophthalmology and Vision Discovery Institute, Medical College of Georgia, Augusta, Georgia
- 3Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia
- 4Department of Anatomy, Mansoura College of Medicine, Mansoura, Egypt
- 5Northwestern University, Chicago, Illinois
- 6Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public
- Health, Madison, Wisconsin
- 7Department of Pathology, Wayne State University, Detroit, Michigan
- Corresponding author: Mohamed Al-Shabrawey, .
OBJECTIVE Arachidonic acid is metabolized by 12-lipoxygenase (12-LOX) to 12-hydroxyeicosatetraenoic acid (12-HETE) and has an important role in the regulation of angiogenesis and endothelial cell proliferation and migration. The goal of this study was to investigate whether 12-LOX plays a role in retinal neovascularization (NV).
RESEARCH DESIGN AND METHODS Experiments were performed using retinas from a murine model of oxygen-induced ischemic retinopathy (OIR) that was treated with and without the LOX pathway inhibitor, baicalein, or lacking 12-LOX. We also analyzed vitreous samples from patients with and without proliferative diabetic retinopathy (PDR). Western blotting and RT-PCR were used to assess the expression of 12-LOX, vascular endothelial growth factor (VEGF), and pigment epithelium–derived factor (PEDF). Liquid chromatography–mass spectrometry was used to assess the amounts of HETEs in the murine retina and human vitreous samples. The effects of 12-HETE on VEGF and PEDF expression were evaluated in Müller cells (rMCs), primary mouse retinal pigment epithelial cells, and astrocytes.
RESULTS Retinal NV during OIR was associated with increased 12-LOX expression and 12-, 15-, and 5-HETE production. The amounts of HETEs also were significantly higher in the vitreous of diabetic patients with PDR. Retinal NV was markedly abrogated in mice treated with baicalein or mice lacking 12-LOX. This was associated with decreased VEGF expression and restoration of PEDF levels. PEDF expression was reduced in 12-HETE–treated rMCs, astrocytes, and the retinal pigment epithelium. Only rMCs and astrocytes showed increased VEGF expression by 12-HETE.
CONCLUSIONS 12-LOX and its product HETE are important regulators of retinal NV through modulation of VEGF and PEDF expression and could provide a new therapeutic target to prevent and treat ischemic retinopathy.
- Received January 4, 2010.
- Accepted November 21, 2010.
- © 2011 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.